Is Inventiva SA halal to invest in?

According to Musaffa's Shariah screening methodology, Inventiva SA (IVA.PA) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Inventiva SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Inventiva SA using these criteria to determine its compliance status.

Can Muslims buy shares of Inventiva SA?

Muslim investors may consider investing in Inventiva SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Inventiva SA classified as NOT HALAL?

Musaffa determines the Shariah status of Inventiva SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Inventiva SA updated?

The Shariah compliance status of Inventiva SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Inventiva SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Inventiva SA?

You can check the latest Shariah compliance status of Inventiva SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Inventiva SA IVA.PA

€4.74 €0.01 (0.11%) 1D

Last Updated: May 15, 12:00 AM·XPAR

IVA.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 18, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Inventiva SA (IVA.PA)

Based on 15 analysts giving stock ratings to Inventiva SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Inventiva SA. Stock Analysis IVA.PA

France Health Care Small Cap Report: 2025 Annual

Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. The company employs 58 full-time employees The company went IPO on 2017-02-15. The firm focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.

Key Statistics of Inventiva SA (IVA.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€4.69€4.90

Today's Open

€4.74

Volume

143.24K

P/E Ratio (TTM)

52 Week Range

€2.56€6.20

Market Cap

901.08M

Avg. Volume

151.71K

Dividend Yield

Financial Metrics & Statements of Inventiva SA (IVA.PA)

FAQ's for Inventiva SA (IVA.PA)

According to Musaffa’s Shariah screening methodology, Inventiva SA (IVA.PA) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.